ATE152776T1 - Test zur bestimmung des glaukoms (poag) durch testen peripherer blutzellen auf 3-alpha- hydroxysteroiddehydrogenase aktivität und dazu geeignetes kit - Google Patents

Test zur bestimmung des glaukoms (poag) durch testen peripherer blutzellen auf 3-alpha- hydroxysteroiddehydrogenase aktivität und dazu geeignetes kit

Info

Publication number
ATE152776T1
ATE152776T1 AT95905938T AT95905938T ATE152776T1 AT E152776 T1 ATE152776 T1 AT E152776T1 AT 95905938 T AT95905938 T AT 95905938T AT 95905938 T AT95905938 T AT 95905938T AT E152776 T1 ATE152776 T1 AT E152776T1
Authority
AT
Austria
Prior art keywords
activity
alpha
hydroxysteroiddehydrogenase
poag
test
Prior art date
Application number
AT95905938T
Other languages
English (en)
Inventor
A Louis Southren
Bernard I Weinstein
Gary G Gordon
Original Assignee
New York Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Medical College filed Critical New York Medical College
Application granted granted Critical
Publication of ATE152776T1 publication Critical patent/ATE152776T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
AT95905938T 1993-12-17 1994-12-14 Test zur bestimmung des glaukoms (poag) durch testen peripherer blutzellen auf 3-alpha- hydroxysteroiddehydrogenase aktivität und dazu geeignetes kit ATE152776T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/169,611 US5376534A (en) 1993-12-17 1993-12-17 Use of decreased 3-alpha-hydroxysteroid dehydrogenase activity in peripheral lymphocytes or other cells of patients with primary open angle glaucoma as a diagnostic indicator

Publications (1)

Publication Number Publication Date
ATE152776T1 true ATE152776T1 (de) 1997-05-15

Family

ID=22616414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95905938T ATE152776T1 (de) 1993-12-17 1994-12-14 Test zur bestimmung des glaukoms (poag) durch testen peripherer blutzellen auf 3-alpha- hydroxysteroiddehydrogenase aktivität und dazu geeignetes kit

Country Status (10)

Country Link
US (1) US5376534A (de)
EP (1) EP0734455B1 (de)
JP (1) JPH09506515A (de)
AT (1) ATE152776T1 (de)
AU (1) AU1436195A (de)
CA (1) CA2175996A1 (de)
DE (1) DE69403093T2 (de)
ES (1) ES2104476T3 (de)
GR (1) GR3024195T3 (de)
WO (1) WO1995016790A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080058429A1 (en) * 2003-02-14 2008-03-06 A Louis Southren Diagnosis Of Primary Open Angle Glaucoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863912A (en) * 1986-05-19 1989-09-05 New York Medical College Use of tetrahydrocortisol in glaucoma therapy

Also Published As

Publication number Publication date
DE69403093D1 (de) 1997-06-12
US5376534A (en) 1994-12-27
CA2175996A1 (en) 1995-06-22
EP0734455A1 (de) 1996-10-02
ES2104476T3 (es) 1997-10-01
WO1995016790A1 (en) 1995-06-22
DE69403093T2 (de) 1997-11-20
AU1436195A (en) 1995-07-03
GR3024195T3 (en) 1997-10-31
JPH09506515A (ja) 1997-06-30
EP0734455B1 (de) 1997-05-07

Similar Documents

Publication Publication Date Title
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
Neuman et al. Tumor necrosis factor‐α and transforming growth factor‐β reflect severity of liver damage in primary biliary cirrhosis
Tolo et al. Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
Baydanoff et al. Age-related changes in the level of circulating elastin-derived peptides in serum from normal and atherosclerotic subjects
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
MX9804305A (es) Analisis sanguineo de proporcion del factor v paradeterminar la susceptibilidad a la tromboembolia.
NO953770L (no) Analysemetode
ATE529743T1 (de) Verfahren und kits zur tumorigenizitätsdiagnose
ATE271225T1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
EP0873421A4 (de) Diagnostisches Verfahren und Reagentiensatz zur Bestimmung des Rh-Blutgruppengenotyps
ATE152776T1 (de) Test zur bestimmung des glaukoms (poag) durch testen peripherer blutzellen auf 3-alpha- hydroxysteroiddehydrogenase aktivität und dazu geeignetes kit
ATE243758T1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
Ireland et al. Apparent heterozygous Type II protein C deficiency caused by the factor V 506 Arg to Gin mutation
Silverstein A rapid protein test for acoustic neurinoma
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
Davidson et al. Salivary amylase in cystic fibrosis: a marker of disordered autonomic function
Pelletier et al. Upper gastrointestinal endoscopy an unrecognized cause of hyperamylasemia
Gersten et al. Failure of inhibitor assay to determine isoamylase distribution
SU1573378A1 (ru) Способ диагностики рефлюксгастрита
Ritter et al. Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterization and prevalence
ATE220458T1 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten
AU578661B2 (en) Method for diagnosis of A.I.D.S.
DE69915437D1 (de) Plasmasammlungen von mehr als 200 gesunden Patienten und davon abgeleiteter Kalibrierstandard
RU95111009A (ru) Способ выявления сенсибилизации к лекарственным аллергенам